Identification of neoantigen-reactive T lymphocytes in the peripheral blood of a patient with glioblastoma

The adoptive transfer of naturally occurring T cells that recognize cancer neoantigens has led to durable tumor regressions in select patients with cancer. However, it remains unknown whether such T cells can be isolated from and used to treat patients with glioblastoma, a cancer that is refractory...

Descripción completa

Detalles Bibliográficos
Autores principales: Leko, Vid, Cafri, Gal, Yossef, Rami, Paria, Biman, Hill, Victoria, Gurusamy, Devikala, Zheng, Zhili, Gartner, Jared J, Prickett, Todd D, Goff, Stephanie L, Robbins, Paul, Lu, Yong-Chen, Rosenberg, Steven A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Immune Cell Therapies and Immune Cell Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286793/
https://www.ncbi.nlm.nih.gov/pubmed/34266885
http://dx.doi.org/10.1136/jitc-2021-002882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286793/
https://www.ncbi.nlm.nih.gov/pubmed/34266885
http://dx.doi.org/10.1136/jitc-2021-002882

Ejemplares similares